BlueSavant AI

BlueSavant AI (BSAI), an early-stage startup incorporated in USA, is transforming autism diagnosis through a blood test that combines AI and gene expressions from RNA-seq to detect autism earlier and more accurate than ever before. This is impactful because it offers a proactive data-driven approach to detect autism for any age even before symptoms appear, thereby alleviating the stress and uncertainty often faced by families during the diagnostic process. This approach opens the door to have a screening simple test for autism integrated into routine childcare procedures applicable for all children not just those showing developmental delays.